What is a Community Advisory Board or “CAB”?
The Washington University AIDS Clinical Trial Unit Community Advisory Board (CAB) was formed in 1988. The CAB assists in the selection and implementation of trials, acts as a liaison to the community and educates members about participation in clinical trials
WE WANT YOUR INPUT – Everyone is invited to attend meetings and become a member of the Community Advisory Board (CAB)
Who can join?
All persons from diverse communities are welcome regardless of medical background, health, or HIV status. We especially encourage those who have taken part in a clinical trial or are currently enrolled in one to participate in the CAB. Everyone is welcome!
The mission of the Community Advisory Boards of the AIDS Clinical Trials Group is to integrate community involvement in the AIDS Clinical Trials Units in order to advance HIV/AIDS research.
CAB meetings provide an opportunity for affected communities, especially clinical trials participants to:
- understand the clinical research process and voice concerns regarding the clinical studies, their development, process and outcomes,
- provide valuable insight about how to attract and best serve the participants,
- make sure that trial participants receive any advocacy they might require,
- build a partnership that will lead to improved knowledge of HIV/AIDS disease,
- give a means to address grievance issues, and
- promote ethical research purposes and practices.
When and Where
CAB meetings are held on the first Wednesday of each month with a recess during July and August. During the COVID-19 pandemic, our meetings are virtual. We meet at 4:30 when there are new protocols to review. When available, the updated meeting agenda will be posted here so you can review the meeting details.
If you would like more information please call Laura Blaire at 314-454-0058.